Although RA is associated with significant morbidity, the increasing number of effective drugs and modes of action has improved the disease outcome. Currently, several US Food and Drug Administration ...

Mean±SEM, n=4 with 10 rings per group, *P<0.05 vs control group. If confirmed in humans, these results could be of potential importance for antiatherosclerotic treatment strategies. It may be ...

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

For the first time since 2019, Illinois regulators have approved new medical conditions to qualify for medical cannabis, all centered on women’s health. Endometriosis, ovarian cysts, uterine ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...

However, there was no significant reduction in the incidence of macrovascular disease in patients with rigorous control of glycemia 3,4. Although ... AGE engagement of the receptor for AGE ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Acne Vulgaris Therapeutics Market Size in the 7MM was ~USD 4,256 Million in 2023 and is projected to ...

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased states. In disease, high ...

目前，国内也涌现了很多创新药企，开发了各种针对自身免疫病发病因子的药物，比如针对IL-4的——司普奇拜单抗（用于治疗：特应性皮炎、慢性鼻窦炎伴鼻息肉）；对IL-1的——利纳西普（用于治疗：青少年冷吡啉相关周期性综合征）；和针对IL-17的——赛立奇单抗（用于治疗：银屑病）等等。